Study results published in The New England Journal of Medicine show the therapy significantly improved hearing in nearly a ...

The findings are the latest setback for weight loss medicines that target a specific cannabinoid receptor and are meant to ...

The company is one of a handful developing a more “selective” URAT1 inhibitor, an approach that’s seen as a way to improve ...

Living with an autoimmune disease often means navigating a lifelong, complex condition. A recent study estimates that ...

The British pharma is adding $500 million, and ADC production capabilities, to a planned Virginia facility. Elsewhere, ...

A settlement could extend the exclusivity of the world’s best-selling HIV medicine to 2036. Elsewhere, an AstraZeneca drug ...

The company believes its lead drug, which is currently in mid-stage testing, could address limitations of other therapies for ...

Libtayo’s latest approval for a type of skin cancer should boost future sales, according to one analyst, but doesn’t have the ...

Nilo Therapeutics, which launched Wednesday, is trying to develop drugs that regulate inflammation and the immune system by ...

Six months after his abrupt resignation as CBER director, Marks has been hired to run discovery and infectious disease work ...

The agency will consider a submission that includes pooled data from ongoing studies, a decision analysts viewed as a notable ...

The acquisition of the well-funded startup is the fourth this year involving companies with technologies that can genetically ...